FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed group of inventions relates to medicine, namely to therapy and immunology, and deals with treatment of autoimmune diseases. For this purpose 3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid or its salt is introduced in the form of a combination or a pharmaceutical composition with one or more of TNFα inhibitors.
EFFECT: invention provides efficient treatment of autoimmune diseases due to synergic action of the said components.
6 cl, 1 ex, 1 tbl
Authors
Dates
2014-07-10—Published
2009-03-25—Filed